Matches in DBpedia 2016-04 for { ?s ?p "Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.It has never been filed for FDA evaluation in the United States, where it is not marketed."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Ranimustine abstract "Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.It has never been filed for FDA evaluation in the United States, where it is not marketed.".
- Q7293058 abstract "Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.It has never been filed for FDA evaluation in the United States, where it is not marketed.".
- Ranimustine comment "Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.It has never been filed for FDA evaluation in the United States, where it is not marketed.".
- Q7293058 comment "Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.It has never been filed for FDA evaluation in the United States, where it is not marketed.".